US · Healthcare

Virpax Pharmaceuticals Inc (VRPX)

Biotechnology

Virpax Pharmaceuticals Inc (VRPX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for VRPX

P/E ratio

18.00

Virpax Pharmaceuticals Inc (VRPX) — FAQ

What is VRPX's P/E ratio?

The price-to-earnings (P/E) ratio for Virpax Pharmaceuticals Inc (VRPX) is 18.00 (data as of 2026-03-25).

Does Virpax Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Virpax Pharmaceuticals Inc (VRPX). Check the MyAverix Finance app for the latest dividend data.

What sector is Virpax Pharmaceuticals Inc in?

Virpax Pharmaceuticals Inc (VRPX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is VRPX listed on?

VRPX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)